• Enteris BioPharma Receives $10M Milestone from Cara Therapeutics contractpharma
    June 15, 2021
    ​The contract development and manufacturing organization (CDMO) Enteris BioPharma received a $10 million milestone payment from Cara Therapeutics related to the license agreement for the Peptelligence oral formulation technology utilized in ...
PharmaSources Customer Service